News

May 24, 2013  •  Research Updates
While many were anxious to accept initial findings showing a drug known as Targretin’s “too good to be true” lab results with Alzheimer...
May 6, 2013  •  Research Updates
Cure Alzheimer’s Fund and National Institute of Mental Health Join in Awarding Millions for Whole Genome Sequencing
May 4, 2013  •  From the Founders
Henry McCance, chairman emeritus of Greylock Partners, co-founded Cure Alzheimer’s Fund in 2005 after getting frustrated with the lack of knowledge about...
April 25, 2013  •  Research Updates
BOSTON— Excessive levels of the protein CD33 can impede the clearance of the plaque-forming protein, amyloid beta, the key component of senile plaques in...
April 15, 2013  •  News
Cure Alzheimer’s Fund is saddened by the terror attack at the Boston Marathon.  Our hearts go out to all who have been affected by these...
April 14, 2013  •  Research Updates
The study, led by Cure Alzheimer’s Research Consortium member Sam Gandy, M.D., Ph.D., of the Icahn School of Medicine at Mount Sinai, examined how...
April 11, 2013  •  From the President/CEO
Good, but never enough until Alzheimer’s is gone!
April 11, 2013  •  Research Updates
Traumatic Brain Injury (TBI) can lead to Neurodegenerative Syndromes that include Alzheimer Disease (AD) and Chronic Traumatic Encephalopathy (CTE) The April...